Unknown

Dataset Information

0

Fluconazole loading dose pharmacokinetics and safety in infants.


ABSTRACT: BACKGROUND:Invasive candidiasis is a leading cause of morbidity and mortality in critically ill infants. Prompt administration of fluconazole and achievement of the therapeutic target (area under the curve 0 to 24 hours >400 mg*h/L) improve outcomes in candidemic patients. A loading dose of fluconazole is advised for older patients but has not been evaluated in infants. We sought to determine the pharmacokinetics and safety of a fluconazole loading dose in infants at risk for invasive fungal infection. METHODS:We enrolled 10 hospitalized infants <60 days old with suspected systemic fungal infection in this open-label study; 9 received a 25-mg/kg fluconazole loading dose followed by a maintenance dose of 12 mg/kg every 24 hours for 4 additional days. Plasma samples were obtained following the loading and steady-state doses (doses 3-5). We used a 1-compartment model to fit the data to estimate pharmacokinetic indices. RESULTS:Data from 57 drug concentrations obtained from 8 infants (median postnatal age, 16 days [interquartile range, 13-32] and median gestational age, 37 weeks [35-38]) showed that the median fluconazole area under the curve 0 to 24 hours (mg*h/L) in this population was 479 (347-496). Of the 8 infants who received the loading dose, 5 (63%) achieved the therapeutic target on the first day of dosing, and all infants achieved a fluconazole 24-hour trough concentration >8 ?g/mL. No adverse events were thought to be related to fluconazole therapy. CONCLUSIONS:A loading dose of fluconazole (25 mg/kg) was safe in this small cohort of young infants and achieved the therapeutic target more rapidly than traditional dosing.

SUBMITTER: Piper L 

PROVIDER: S-EPMC3078721 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fluconazole loading dose pharmacokinetics and safety in infants.

Piper Lauren L   Smith P Brian PB   Hornik Christoph P CP   Cheifetz Ira M IM   Barrett Jeffrey S JS   Moorthy Ganesh G   Hope William W WW   Wade Kelly C KC   Cohen-Wolkowiez Michael M   Benjamin Daniel K DK  

The Pediatric infectious disease journal 20110501 5


<h4>Background</h4>Invasive candidiasis is a leading cause of morbidity and mortality in critically ill infants. Prompt administration of fluconazole and achievement of the therapeutic target (area under the curve 0 to 24 hours >400 mg*h/L) improve outcomes in candidemic patients. A loading dose of fluconazole is advised for older patients but has not been evaluated in infants. We sought to determine the pharmacokinetics and safety of a fluconazole loading dose in infants at risk for invasive fu  ...[more]

Similar Datasets

| S-EPMC3444624 | biostudies-literature
| S-EPMC5198845 | biostudies-literature
| S-EPMC3962781 | biostudies-literature
| S-EPMC4862454 | biostudies-literature
| S-EPMC6535522 | biostudies-literature
| S-EPMC6326087 | biostudies-other
| S-EPMC3421038 | biostudies-literature
| S-EPMC2663098 | biostudies-literature
| S-EPMC2863654 | biostudies-literature
| S-EPMC6927883 | biostudies-literature